Back to News

Observe Medical ASA – collaborations with Yallow Life Science AS and Norway Health Tech

04th February, 2021

Oslo February 4, 2021 - Observe Medical ASA announces strengthened presence in Norway through a partnership agreement with the Norwegian medtech agency Yallow Life Science AS and an enhanced collaboration with Norway Health Tech.

Observe Medical, with headquarters in Oslo, Norway, is launching Sippi® automated digital urine meter in selected markets in Europe. The short term focus is the acceleration of Sippi® in clinical use in the Nordics, and to further strengthen the presence in Norway, Observe Medical is now entering a collaboration with the medtech focused consultancy company, Yallow Life Science AS, and the not-for-profit cluster, Norway Health Tech, both based in Oslo.

The new collaborations follow Observe Medical’s recent expansion in the Nordics through the acquisition and integration of Sylak AB, that brought a broad portfolio of medtech products and an experienced sales team. In the coming period, the sales operations will be further built up through an expansion of the direct sales team in the Nordics.

Norway Health Tech is a leading Norwegian health cluster focusing on innovation by facilitating collaboration between academia, healthcare and industry, and Observe Medical is already an active member.

Yallow is an Oslo-based medtech focused consultancy firm with specific competency in design and development with a focus on medical devices and connected care, they have a strong clinical network and are also members in Norway Health Tech. From early February Yallow is headquartered at the Healthcare hub at Oslo Science Park.

“We are excited to enter the enhanced collaboration with Yallow and Norway Health Tech. We will be able to access the competence of the Yallow team, and the strong innovation resources centered within Norway Health Tech. Both of them are situated at Oslo Life Science Park, close to The University of Oslo, the university hospitals and research institutes along with bustling start-up hubs like Aleap, Start-up Lab and The Life Science Cluster. I am positive that this will drive Sippi® clinical use and portfolio sales growth in the Nordics,” says Björn Larsson, CEO of Observe Medical.

“At Yallow we are of course proud and honored to enter into such an agreement and see great potential in the collaboration with Observe Medical, especially now when moving close to the Norway Health Tech office. We are looking forward to making a difference both for Observe Medical and for the life science sector in Norway” says Petter Arlehed, CEO of Yallow.

“Norway Health Tech is excited to welcome Yallow to our facilities at Oslo Science Park and using our strong competence and network to strengthen collaboration with Observe Medical – we look forward to bringing together synergies for the benefit of Norway’s life science sector and ultimately for patients in Norway and worldwide” says Anita Moe Larsen, Head of Communication, Norway Health Tech.

For further information, please see company press release
About usTeamNewsInvestmentsContactCasesESGInvestor relationsPrivacy Policy